HBV
HBV(乙型肝炎病毒)
HBV (hepatitis B virus) is a double-strand DNA virus that belongs to the hepadaviridase famlity. It cause transient and acute liver infections which lead to cirrhosis and liver cancer. It is propagated through blood, sex and mother-fetus transmission.
HBV 相关产品(75)
- GC12555GS-9620 (Vesatolimod)CAS: 1228585-88-3纯度: >99.50%
GS-9620 (Vesatolimod)是一种具口服活性的有效的Toll样受体7(TLR7)激动剂,EC 50 值为291nM,具有抗病毒作用。
- GC10997OxethazaineCAS: 126-27-2纯度: >99.00% / >98.00% / >95.00%
Oxethazaine (Oxetacaine) 是芬特明酸性的前体,是一种具有抗酸和口服活性的镇痛剂。
- GC11689Cetylpyridinium ChlorideCAS: 123-03-5纯度: >99.00%
A quaternary ammonium with broad-spectrum antiseptic activities
- GC17567Doxorubicin (Adriamycin) HClCAS: 25316-40-9纯度: >99.50% / >98.00%
An anthracycline antitumor antibiotic
- GC32065Bay 41-4109 (Bayer 41-4109)CAS: 298708-81-3纯度: >98.00%
BAY 41-4109 是一种有效的人类乙型肝炎病毒 (HBV) 抑制剂,IC50 为 53 nM。
- GC32071Squalamine (MSI-1256)CAS: 148717-90-2纯度: >98.00%
Squalamine (MSI-1256)(MSI-1256) 是一种氨基甾醇化合物,具有强大的广谱抗病毒活性。
- GC32073Morphothiadin (GLS4)CAS: 1092970-12-1纯度: >99.00%
Morphothiadin (GLS4)是一种强效抗病毒剂,可抑制乙型肝炎病毒(HBV)复制,IC 50 值为12nM。
- GC32104Inarigivir (ORI-9020)CAS: 475650-36-3
Inarigivir (ORI-9020) (ORI-9020) 是一种二核苷酸抗病毒药物,可显着降低表达乙型肝炎病毒的转基因小鼠的肝脏 HBV DNA。
- GC32144Osalmid (Oxaphenamide)CAS: 526-18-1纯度: >98.50%
Osalmid suppresses ribonucleotide reductase (RNR) activity in a concentration-dependent manner, with a 50% RR activity-inhibitory concentration (IC50) of 8.23 μM.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC11295 | Telbivudine | 3424-98-4 | >99.50% | |
An antiviral nucleoside analog | ||||
| GC12555 | GS-9620 (Vesatolimod) | 1228585-88-3 | >99.50% | |
GS-9620 (Vesatolimod)是一种具口服活性的有效的Toll样受体7(TLR7)激动剂,EC 50 值为291nM,具有抗病毒作用。 | ||||
| GC13522 | Merimepodib | 198821-22-6 | >98.50% | |
An IMPDH inhibitor | ||||
| GC16841 | Adefovir Dipivoxil | 142340-99-6 | >99.50% | |
Adefovir Dipivoxil是一种口服有效的逆转录酶抑制剂。 | ||||
| GP10047 | HBcAg [Hepatitis B virus] (18-27) | - | - | |
Indicator of active viral replication | ||||
| GP10068 | surface antigen (208-215) [Hepatitis B Virus] | - | - | |
Surface antigen used for signs of infection | ||||
| GC10997 | Oxethazaine | 126-27-2 | >99.00% / >98.00% / >95.00% | |
Oxethazaine (Oxetacaine) 是芬特明酸性的前体,是一种具有抗酸和口服活性的镇痛剂。 | ||||
| GC11689 | Cetylpyridinium Chloride | 123-03-5 | >99.00% | |
A quaternary ammonium with broad-spectrum antiseptic activities | ||||
| GC12125 | Tenofovir | 147127-20-6 | >99.50% | |
An HIV and HBV antiviral | ||||
| GC12635 | Clevudine | 163252-36-6 | >99.00% | |
An antiviral nucleoside analog | ||||
| GC15067 | Tenofovir Disoproxil Fumarate | 202138-50-9 | >99.50% | |
A prodrug of the antiviral tenofovir | ||||
| GC16092 | Entecavir Hydrate | 209216-23-9 | >99.50% | |
An antiviral nucleoside analog | ||||
| GC17567 | Doxorubicin (Adriamycin) HCl | 25316-40-9 | >99.50% / >98.00% | |
An anthracycline antitumor antibiotic | ||||
| GC17997 | Niranthin | 50656-77-4 | - | |
Niranthin,一种具有广泛药理活性的木脂素。 | ||||
| GC18304 | Bicyclol | 118159-48-1 | >98.00% | |
A hepatoprotective agent | ||||
| GC19014 | AB-423 | 1572510-80-5 | >99.50% | |
AB-423 是一种 HBV 衣壳组装抑制剂,有效抑制 HBV 复制,在细胞中的 EC50/EC90 为 0.08-0.27 μM/0.33-1.32 μM。 | ||||
| GC19208 | JNJ-632 | 1572510-42-9 | >99.50% | |
A modulator of HBV capsid assembly | ||||
| GC32065 | Bay 41-4109 (Bayer 41-4109) | 298708-81-3 | >98.00% | |
BAY 41-4109 是一种有效的人类乙型肝炎病毒 (HBV) 抑制剂,IC50 为 53 nM。 | ||||
| GC32071 | Squalamine (MSI-1256) | 148717-90-2 | >98.00% | |
Squalamine (MSI-1256)(MSI-1256) 是一种氨基甾醇化合物,具有强大的广谱抗病毒活性。 | ||||
| GC32073 | Morphothiadin (GLS4) | 1092970-12-1 | >99.00% | |
Morphothiadin (GLS4)是一种强效抗病毒剂,可抑制乙型肝炎病毒(HBV)复制,IC 50 值为12nM。 | ||||
| GC32093 | Entecavir (BMS200475) | 142217-69-4 | - | |
An antiviral nucleoside analog | ||||
| GC32104 | Inarigivir (ORI-9020) | 475650-36-3 | - | |
Inarigivir (ORI-9020) (ORI-9020) 是一种二核苷酸抗病毒药物,可显着降低表达乙型肝炎病毒的转基因小鼠的肝脏 HBV DNA。 | ||||
| GC32115 | Bay 41-4109 racemate | 298708-79-9 | >98.00% | |
An antiviral agent | ||||
| GC32144 | Osalmid (Oxaphenamide) | 526-18-1 | >98.50% | |
Osalmid suppresses ribonucleotide reductase (RNR) activity in a concentration-dependent manner, with a 50% RR activity-inhibitory concentration (IC50) of 8.23 μM. | ||||
